Raman Imaging And Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 31-10-2024
- Paid Up Capital ₹ 1.95 Cr
as on 31-10-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.05 Cr
as on 31-10-2024
- Revenue %
(FY 2023)
- Profit -190312.96%
(FY 2023)
- Net Worth 2452.16%
(FY 2023)
- Total Assets 27546.16%
(FY 2023)
About Raman Imaging And Diagnostic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.95 Cr.
The company currently has active open charges totaling ₹10.05 Cr.
Vihag Raman and Riya Kumar serve as directors at the Company.
- CIN/LLPIN
U85300BR2020PTC049646
- Company No.
049646
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Raman Imaging And Diagnostic?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vihag Raman | Director | 16-Dec-2020 | Current |
Riya Kumar | Director | 20-Nov-2021 | Current |
Financial Performance of Raman Imaging And Diagnostic.
Raman Imaging And Diagnostic Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 190312.96% decrease in profit. The company's net worth Soared by an impressive increase of 2452.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of Raman Imaging And Diagnostic?
In 2023, Raman Imaging And Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Dev Institute Of Nuclear Medicine Private LimitedActive 20 years 9 months
Vihag Raman is a mutual person
- Ramans Healthcare And Diagnostics Private LimitedActive 7 years 3 months
Vihag Raman and Riya Kumar are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 14 Mar 2024 | ₹1.50 M | Open |
Hdfc Bank Limited Creation Date: 17 Nov 2022 | ₹9.90 Cr | Open |
How Many Employees Work at Raman Imaging And Diagnostic?
Raman Imaging And Diagnostic has a workforce of 11 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raman Imaging And Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raman Imaging And Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.